# NorthSea Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/northsea-therapeutics-b-v

- Industry: Biotechnology
- Headquarters: Amsterdam, Netherlands
- Website: www.northseatherapeutics.com
- Total disclosed funding: $150M
- Latest round: Series C (Dec 17, 2021)
- Investors on record: 9

## About

Founded in 2017 and based in North Holland, Netherlands NorthSea Therapeutics B.V. operates as a clinical-stage biotechnology company specializing in the development of structurally engineered fatty acid therapeutics to treat metabolic, inflammatory, and fibrotic diseases.

## Funding rounds

- Series C, Dec 17, 2021, $80M — Sofinnova Investments, Novo Holdings, Forbion, BioGeneration Ventures, Ysios Capital Partners, Hercules Capital, New Science Ventures, VenBio
- Series B, Jan 8, 2020, $40M — Sofinnova Investments, Forbion, BioGeneration Ventures, New Science Ventures, VenBio, Novo Seeds
- Series A, Dec 12, 2017, $29M — Forbion, BioGeneration Ventures, New Science Ventures, Novo Seeds

## Investors

- Forbion (https://capitalatlas.ai/funds/forbion) — Series A, Series B, Series C
- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Series A, Series B, Series C
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A, Series B, Series C
- Novo Seeds — Series A, Series B
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B, Series C
- VenBio (https://capitalatlas.ai/funds/venbio) — Series B, Series C
- Novo Holdings — Series C
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series C
- Hercules Capital (https://capitalatlas.ai/funds/hercules-capital) — Series C